top of page

doctor'sIntroduction

training instructor

Yasuo Ohnishi　Yasuo Ohnishi, MD, Ph.D.

Graduation year: H16

common name

■ Specialized field

  ・Orthopedics ・Sports medicine ・Sports injuries and disabilities

  ・Joint surgery   ・Arthroscopic surgery

 

■ Society-certified physicians, etc.

  ・Doctor of Medicine

  ・Japanese Orthopedic Society Specialist

  ・ Sports doctor certified by the Japan Sports Association

  ・ Japanese orthopedic certified rheumatologist

  ・ Japanese orthopedic certified spinal cord doctor

■ Work history

2004 Tokyo Saiseikai Central Hospital

2006 Kobe University Hospital

2007 Prefectural Kakogawa Hospital

2008 Kagawa University Hospital

2009 Kobe University Hospital

2012 Hyogo Central Hospital

2013 Kobe University Hospital

2014 University of Vienna (AKH)

2016 University of Occupational and Environmental Health Wakamatsu Hospital

■ Academic societies and activities in society

Japanese Orthopedic Association

Japanese Society of Clinical Sports Medicine

Japanese Society of Arthroscopy, Knee and Sports Orthopedic Surgery

Japanese Society of Foot Surgery

Japan Hip Society

Japanese Society for Artificial Joints

Pain Clinic Society

■ Educational background

1996 Graduated from Koyo Gakuin High School

2004 Graduated from Kobe University School of Medicine

2013 Ph.D., Graduate School of Medicine, Kobe University

■ Team, Tournament Accompaniment

2015-Deuson Kobe team doctor

2007～ Hyogo Prefectural Football Association Medical Committee

2015～ JOC strengthening staff

■To everyone

I was born in Akashi City, Hyogo Prefecture, which faces the Seto Inland Sea. As for sports, when I was in high school, I belonged to the university and the soccer club, and I was able to do my best as a forward. When I was in college, I was the top scorer in the Kinki Medical and Dental League, won the West Japan Medical Sports Tournament twice, and won the runner-up twice, but I myself suffered from many injuries.

After becoming a doctor, I became a supporter, and I am interested in how to deal with and prevent injuries to athletes, especially soccer, and I have devoted myself to them every day.

I am studying at this Wakamatsu Hospital to acquire further experience and knowledge. I'm a Kansai native, but I'm willing to study and devote myself with the locals, so please support me! !

■ Academic papers　　　　　　　　　　　　　　　　　　　　　

  • Ohnishi Y, et al.: Arthroscopic technique for isolate posterolateral rotational instability of the knee.

  • Onishi Y, et al. : Transcutaneous application of CO2 enhances the antitumor effect of radiation therapy in human malignant fibrous histiocytoma. Int J Oncol. 2014;45(2):732-738.

  • Onishi Y, et al. : Regulation of mitochondrial proliferation by PGC-1 induces cellular apoptosis in musculoskeletal malignancies. 2014; 4:3916

  • Onishi Y, et al.: Transcutaneous Application of Carbon Dioxide (CO2) Induces Mitochondrial Apoptosis in Human Malignant Fibrous Histiocytoma.2012;7(11): e49189.

  • Onishi Y, et al. : Transcutaneous application of carbon dioxide (CO2) enhances chemosensitivity by reducing hypoxic conditions in human malignant fibrous histiocytoma. J Cancer Sci Ther. 2012; 4: 174-181.

  • Onishi Y, et al.:PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.Int J Oncol. 2012;40(6):1839-48.

  • Onishi Y, et al. : Magnetic Resonance Imaging Findings of Microgeodic Disease of the Toe : A case report. 2010 Mar;31(3):251-3.

  • Onishi Y, et al. : Treatment of chronic post-traumatic hyperextension deformity of proximal interphalangeal joint using the suture anchor : A case report. 2007;12(1):47-9

　　　　　

■Main announcement

  • The 8th Combined Meeting of Orthopedic Research Societies. Venice, Italy. October 13-16 2013. The effect of reoxygenation using a novel CO2 therapy on radiosensitivity in human malignant fibrous histiocytoma cells.

  • Annual Meeting, American Academy of Orthopedic Surgeons. Chicago, USA. Marach 19-23 2013. Transcutaneous Application of CO2 Induces Mitochondrial Apoptosis in Human Malignant Tumors

  • The 59th Annual Meeting, Orthopedic Research Society. SanAntonio, USA. Jan 26-30 2013. Regulation of Mitochondrial Number Induces Apoptosis in Musculoskeletal Malignancies

  • The 59th Annual Meeting, Orthopedic Research Society. SanAntonio, USA. Feb 26-30 2013. Transcutaneous Application of CO2 Induced Mitochondrial Apoptosis in Human Malignant Tumors

  • The 27th Annual Research Meeting of the Japanese Orthopedic Association. Nagoya, Japan. Octorber 26-27, 2012. Regulation of the mitochondrial number is a potent therapeutic tool for malignant musculoskeletal tumors.

  • The 27th Annual Research Meeting of the Japanese Orthopedic Association. Nagoya, Japan. Octorber 26-27, 2012. Transcutaneous Application of CO2 may be a novel therapeutic strategy for musculoskeletal malignancies.

  • The 9th Asia Pacific Musculoskeletal Tumor Society Meeting. Kuala Lumpur, Malaysia. Sep 7-9, 2012. Regulation of Mitochondrial Number Induces Cellular Apoptosis in Human Sarcoma.

  • The 9th Asia Pacific Musculoskeletal Tumor Society Meeting. Kuala Lumpur, Malaysia. Sep 7-9, 2012. Transcutaneous Application of CO2 induced Mitochondrial Apoptosis in Human Malignant Tumors.

  • The 45th Annual Musculoskeletal Tumor Meeting of the Japanese Orthopedic Association. Tokyo, Japan. July 14-15, 2012.

  • The 45th Annual Musculoskeletal Tumor Meeting of the Japanese Orthopedic Association. Tokyo, Japan. July 14-15, 2012.

  • The 58th Annual Meeting, Orthopedic Research Society. San Francisco, USA. Feb 4-7 2012.

  • The 58th Annual Meeting, Orthopedic Research Society. SanFrancisco, USA. Feb 4-7 2012. Transcutaneous application of CO2 induced mitochondrial apoptosis in human malignant fibrous histiocytoma.

  • The 58th Annual Meeting, Orthopedic Research Society. SanFrancisco, USA. Feb 4-7 2012. Transcutaneous application of CO2 enhanced radiosensitivity in human malignant histiocytoma cells

  • The 58th Annual Meeting, Orthopedic Research Society. SanFrancisco, USA. Feb 4-7 2012. Protein kinase D1 negatively regulates invasion and migration ability of human osteosarcoma cells.

  • 2011 Combined Meeting of the Connective Tissue Oncology Society and the Musculoskeletal Tumor Society. Chicago, USA. October 26-29 2011.

  • The 26th Annual Research Meeting of the Japanese Orthopedic Association. Gunma, Japan. Octorber 20-21, 2011. Mitochondrial proliferation by PGC-1a overexpression induces apoptosis in MFH cells.

  • The 2011 European Multidisciplinary Cancer Congress. Stockholm, Sweden. September 23-27 2011.

  • The 44th Annual Musculoskeletal Tumor Meeting of the Japanese Orthopedic Association. Koyto, Japan. July 14-15, 2011.

  • The 9th International symposium on targeted anticancer therapy. Paris, France. Mar March 7-9 2011. PKD1 inhibits invasion and migration ability of osteosarcoma cells via MMP-2 and -9.

  • The 57th Annual Meeting, Orthopedic Research Society. Long Beach, USA. Jan 13-16 2011. Silencing of PKD1 expression increased migration ability of human osteosarcoma cells.

  • The 25th Annual Research Meeting of the Japanese Orthopedic Association, Kyoto, Japan. Octorber 2010. Role of PKD1 in musculoskeletal tumors.

  • The 43th Annual Musculoskeletal Tumor Meeting of the Japanese Orthopedic Association. Tokyo, Japan. July 21-22, 2010. Expression of PKD1 in musculoskeletal tumors.

bottom of page